PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP)

Q: What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share in Q4 2022?

113 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share for Q4 2022. Use the holders table for investor-level position and value details.

CUSIP: 69353Y103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common stock, par value $0.00001 per share
Shares outstanding: 53,320,277
Total 13F shares: 54,555,170
Share change: -3,640,413
Total reported value: $474,625,571
Put/Call ratio: 37%
Price per share: $8.70
Number of holders: 113
Value change: -$38,255,414
Number of buys: 46
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	12%	6,563,077	$78,101,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	8.8%	4,706,089	$56,003,000	—	30 Sep 2022	13F
RTW INVESTMENTS, LP	13F	Company	8.2%	4,356,920	$51,847,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	7.3%	3,897,050	$46,375,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	6.4%	3,433,965	$40,865,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	6.3%	3,360,323	$39,987,000	—	30 Sep 2022	13F
Boxer Capital, LLC	13F	Company	5.9%	3,163,795	$37,649,000	—	30 Sep 2022	13F
Avoro Capital Advisors LLC	13F	Company	5.7%	3,060,000	$36,414,000	—	30 Sep 2022	13F
Euclidean Capital LLC	13F 3/4/5	Company · 10%+ Owner	4.4%	2,336,909	$27,809,000	—	30 Sep 2022	13F 3/4/5
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.2%	1,710,265	$20,352,000	—	30 Sep 2022	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	3%	1,614,911	$19,217,000	—	30 Sep 2022	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	2.8%	1,517,246	$18,055,000	—	30 Sep 2022	13F
Nextech Invest Ltd.	13F	Company	2.6%	1,385,807	$16,491,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	2.5%	1,313,868	$15,635,000	—	30 Sep 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	1,093,116	$13,008,000	—	30 Sep 2022	13F
OUP Management Co., LLC	13F	Company	1.9%	989,232	$11,772,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	1.8%	969,498	$11,537,000	—	30 Sep 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	1.8%	947,876	$11,280,000	—	30 Sep 2022	13F
Woodline Partners LP	13F	Company	1.7%	899,307	$10,702,000	—	30 Sep 2022	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.6%	879,462	$10,466,000	—	30 Sep 2022	13F
PFM Health Sciences, LP	13F	Company	1.6%	855,164	$10,176,000	—	30 Sep 2022	13F
INTERWEST PARTNERS X LP	3/4/5	10%+ Owner	— class O/S missing	4,502,480	$10,040,531	—	13 Jul 2021	3/4/5
FMR LLC	13F	Company	1.4%	773,096	$9,200,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	645,141	$7,677,000	—	30 Sep 2022	13F
PERSONAL CFO SOLUTIONS, LLC	13F	Company	1%	550,342	$6,549,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.99%	526,464	$6,265,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.89%	474,371	$5,645,000	—	30 Sep 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.87%	463,346	$5,514,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.68%	364,356	$4,336,000	—	30 Sep 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.6%	322,024	$3,832,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.59%	316,518	$3,767,000	—	30 Sep 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.54%	289,318	$3,443,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	0.49%	262,910	$3,129,000	—	30 Sep 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.47%	250,000	$2,975,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.47%	248,476	$2,957,000	—	30 Sep 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.44%	234,042	$2,785,000	—	30 Sep 2022	13F
Monarch Partners Asset Management LLC	13F	Company	0.39%	210,370	$2,503,000	—	30 Sep 2022	13F
Thilo Schroeder	3/4/5	Director	— class O/S missing	1,101,283	$2,455,861	—	06 Oct 2021	3/4/5
BARCLAYS PLC	13F	Company	0.36%	193,871	$2,308,000	—	30 Sep 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.35%	187,800	$2,235,000	—	30 Sep 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.33%	178,284	$2,121,581	—	30 Sep 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.33%	178,078	$2,119,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	160,496	$1,910,000	—	30 Sep 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.29%	154,500	$1,839,000	—	30 Sep 2022	13F
Verition Fund Management LLC	13F	Company	0.27%	144,146	$1,715,000	—	30 Sep 2022	13F
EVOKE WEALTH, LLC	13F	Company	0.25%	133,122	$1,584,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.23%	122,453	$1,457,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	0.22%	119,845	$1,426,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.22%	116,411	$1,385,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.19%	103,474	$1,231,000	—	30 Sep 2022	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q4 2022

As of 31 Dec 2022, PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,555,170 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, JPMORGAN CHASE & CO, BlackRock Inc., STATE STREET CORP, Boxer Capital, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, Euclidean Capital LLC, and INTERWEST VENTURE MANAGEMENT CO. This page lists 113 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

116

Q4 2022 holders

113

Holder diff

-3

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.